Patent Blog
  • Contribute
  • Recommend
  • Subscribe
  • Login
  • Our Services

TODAY’S PATENT – MODULATION OF NK CELL ANTIGEN SPECIFIC EFFECTOR ACTIVITY BY MODULATION OF CXCR6 (CD186)

  • Older
  • Newer

TODAY’S PATENT – MODULATION OF NK CELL ANTIGEN SPECIFIC EFFECTOR ACTIVITY BY MODULATION OF CXCR6 (CD186)

Today’s patent was invented by Ulrich Von Andrian and Silke Paust on January 23, 2018, bearing patent no. US9872905.

The instant invention is based, at least in part, on the discovery that CXCR6 plays a critical role in antigen-specific effector function of NK cells. Accordingly, the invention provides, among other things, methods for modulation of antigen-specific NK cell effector function, methods for identifying modulators of antigen-specific NK cell effector function.

  • Categories
    Today's Patent
  • Author

    Tanya Janghel

[boomdevs_toc]

Get Monthly

Global IP Updates

Join our community of over 10,000 subscribers and receive monthly updates on the latest IPR news and changes from around the globe.

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *

Related Posts

TODAY’S PATENT – SUPPORTING DEVICE, CHARGING DEVICE AND CONTROLLER SYSTEM 

TODAY’S PATENT –MARTIAL ARTS SHIN GUARD

TODAY’S PATENT – FACIAL CLEANER

Lex Protector

International Law Office

🇺🇸 +1 888 890 6411

Ip Enforcement

  • Copyright Enforcement
  • Utility Patent Enforcement
  • Design Patent Enforcement
  • Trademark Enforcement

Copyright Registration

  • USA Copyright Registration
  • Indian Copyright Registration
  • Amazon Brand Registration

Subscribe

© Copyright 2020. All rights Reserved

  • Terms & Conditions
  • Privacy Policy

Contribute

Recommend

    Subscribe